These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 31720820)
21. Prospective, open-label safety study of intravenous recombinant tissue plasminogen activator in wake-up stroke. Barreto AD; Fanale CV; Alexandrov AV; Gaffney KC; Vahidy FS; Nguyen CB; Sarraj A; Rahbar M; Grotta JC; Savitz SI; Ann Neurol; 2016 Aug; 80(2):211-8. PubMed ID: 27273860 [TBL] [Abstract][Full Text] [Related]
22. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome. Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065 [TBL] [Abstract][Full Text] [Related]
23. Addressing a real-life problem: treatment with intravenous thrombolysis and mechanical thrombectomy in acute stroke patients with an extended time window beyond 4.5 h based on computed tomography perfusion imaging. Feil K; Reidler P; Kunz WG; Küpper C; Heinrich J; Laub C; Müller K; Vöglein J; Liebig T; Dieterich M; Kellert L Eur J Neurol; 2020 Jan; 27(1):168-174. PubMed ID: 31349393 [TBL] [Abstract][Full Text] [Related]
24. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke. Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399 [TBL] [Abstract][Full Text] [Related]
25. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP). Thomalla G; Fiebach JB; Østergaard L; Pedraza S; Thijs V; Nighoghossian N; Roy P; Muir KW; Ebinger M; Cheng B; Galinovic I; Cho TH; Puig J; Boutitie F; Simonsen CZ; Endres M; Fiehler J; Gerloff C; Int J Stroke; 2014 Aug; 9(6):829-36. PubMed ID: 23490032 [TBL] [Abstract][Full Text] [Related]
26. Impact of thrombolysis in acute ischaemic stroke without occlusion: an observational comparative study. Ajili N; Decroix JP; Preda C; Labreuche J; Lopez D; Bejot Y; Michel P; Sévin-Allouet M; Sibon I; Vergnet S; Wang A; Sanda N; Mazighi M; Bourdain F; Lapergue B Eur J Neurol; 2016 Aug; 23(8):1380-6. PubMed ID: 27222165 [TBL] [Abstract][Full Text] [Related]
27. Predictive role of pre-thrombolytic hs-CRP on the safety and efficacy of intravenous thrombolysis in acute ischemic stroke. Cheng XD; Wang DZ; Zhang Q; Wang JH; Li BH; Zhang X; Zhang J; Zhou S; Jia LJ; Wang LR; Yu NW BMC Neurol; 2023 Jun; 23(1):244. PubMed ID: 37353783 [TBL] [Abstract][Full Text] [Related]
28. Timing of recanalization and outcome in ischemic-stroke patients treated with recombinant tissue plasminogen activator. Wei XE; Zhao YW; Lu J; Li MH; Li WB; Zhou YJ; Li YH Acta Radiol; 2015 Sep; 56(9):1119-26. PubMed ID: 25182802 [TBL] [Abstract][Full Text] [Related]
29. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models. Nisar T; Hanumanthu R; Khandelwal P J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036 [TBL] [Abstract][Full Text] [Related]
31. Modified DWI-FLAIR mismatch guided thrombolysis in unknown onset stroke. Jakubicek S; Krebs S; Posekany A; Ferrari J; Szabo J; Siarnik P; Lang W; Sykora M J Thromb Thrombolysis; 2019 Feb; 47(2):167-173. PubMed ID: 30415393 [TBL] [Abstract][Full Text] [Related]
32. Mechanical Thrombectomy for Acute Stroke: Early versus Late Time Window Outcomes. Bhan C; Koehler TJ; Elisevich L; Singer J; Mazaris P; James E; Zachariah J; Combs J; Dejesus M; Tubergen T; Packard L; Min J; Wees N; Khan N; Mulderink T; Khan M J Neuroimaging; 2020 May; 30(3):315-320. PubMed ID: 32072729 [TBL] [Abstract][Full Text] [Related]
33. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke. Kim DH; Lee DS; Nah HW; Cha JK BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461 [TBL] [Abstract][Full Text] [Related]
34. Thrombolytic Treatment in Wake-Up Stroke: A Propensity Score-Matched Analysis of Treatment Effectiveness in the Norwegian Stroke Registry. Søyland MH; Tveiten A; Eltoft A; Øygarden H; Varmdal T; Indredavik B; Mathiesen EB J Am Heart Assoc; 2024 Feb; 13(3):e032309. PubMed ID: 38293909 [TBL] [Abstract][Full Text] [Related]
35. Predictors of thrombolysis in the telestroke and non telestroke settings for hypertensive acute ischemic stroke patients. Brecthel L; Gainey J; Penwell A; Nathaniel TI BMC Neurol; 2018 Dec; 18(1):215. PubMed ID: 30577762 [TBL] [Abstract][Full Text] [Related]
36. Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients. Poupore N; Strat D; Mackey T; Brown K; Snell A; Nathaniel TI Lipids Health Dis; 2020 May; 19(1):84. PubMed ID: 32375780 [TBL] [Abstract][Full Text] [Related]
37. Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator. Nighoghossian N; Hermier M; Adeleine P; Derex L; Dugor JF; Philippeau F; Ylmaz H; Honnorat J; Dardel P; Berthezène Y; Froment JC; Trouillas P Stroke; 2003 Feb; 34(2):458-63. PubMed ID: 12574560 [TBL] [Abstract][Full Text] [Related]
38. [Prerequisites, indications and contraindications of IV-lysis of ischemic stroke with rt-PA]. Marx P; Hartmann A; Leistner S; Nohr R; Koennecke HC Fortschr Neurol Psychiatr; 2001 Aug; 69(8):346-52. PubMed ID: 11584683 [TBL] [Abstract][Full Text] [Related]